Targeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrin

Journal of Drug Targeting

Volumn 15, Issue 9, 2007, Pages 585-594

  Weeke Klimp, Alida H ^a   Bartsch, Martin ^b   Morselt, Henriëtte W M ^a   Van Veen Hof, Ingrid ^b   Meijer, Dirk K F ^b   Scherphof, Gerrit L ^b   Kamps, Jan A A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Gene targeting; Hepatocytes; Lactoferrin; Non parenchymal liver cells; Stabilized plasmid lipid particles

Indexed keywords

DRUG CARRIER; ETHER DERIVATIVE; LACTOFERRIN; LIPOSOME; RADIOISOTOPE; STABILIZED PLASMID LIPID PARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CELL STRAIN COS7; CONTROLLED STUDY; COVALENT BOND; GENETIC TRANSFECTION; HEP 2 CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIGAND BINDING; LIVER CELL; LIVER PARENCHYMA; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; REPORTER GENE; TARGET CELL;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; HEPATOCYTES; HUMANS; LACTOFERRIN; LIPIDS; MALE; PLASMIDS; RATS; TRANSFECTION;

EID: 35649003344     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701502889     Document Type: Article

References (51)

1. Andersen, JH, Osbakk, SA, Vorland, LH, Traavik, T. and Gutteberg, TJ (2001) Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res, 51, pp. 141-149.
2. Armeanu, S., Lauer, UM, Smirnow, I., Schenk, M., Weiss, TS, Gregor, M. and Bitzer, M. (2003) Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res, 63, pp. 2369-2372.
3. Bartsch, M., Weeke-Klimp, AH, Meijer, DKF, Scherphof, GL and Kamps, JAAM (2002) Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells. Pharm Res, 19, pp. 676-680.
4. Beljaars, L., Bakker, HI, Van der Strate, BW, Smit, C., Duijvestijn, AM, Meijer, DKF and Molema, G. (2002) The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues. Pharm Res, 19, pp. 54-62.
5. Bijsterbosch, MK, Ziere, GJ and Van Berkel, TJ (1989) Lactosylated low density lipoprotein: A potential carrier for the site-specific delivery of drugs to Kupffer cells. Mol Pharmacol, 36, pp. 484-489.
6. Böttcher, CJF, Van Gent, CM and Pries, C. (1961) A rapid and sensitive sub-micro phosphorus determination. Anal Chim Acta, 24, pp. 204-205.
7. Bradley, AJ, Devine, DV, Ansell, SM, Janzen, J. and Brooks, DE (1998) Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem Biophys, 357, pp. 185-194.
8. Brunner, S., Sauer, T., Carotta, S., Cotten, M., Saltik, M. and Wagner, E. (2000) Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther, 7, pp. 401-407.
9. Casteleijn, E., Van Rooij, HC, Van Berkel, TJ and Koster, JF (1986) Mechanism of glucagon stimulation of fructose-1,6-bisphosphatase in rat hepatocytes. Involvement of a low-Mr activator. FEBS Lett, 201, pp. 193-197.
10. Chen, T., Palmer, LR, Fenske, DB, Lam, AMI, Wong, KF and Cullis, PR (2004) Distal cationic poly(ethylene glycol) lipid conjugates in large unilamellar vesicles prepared by extrusion enhance liposomal cellular uptake. J Liposome Res, 14, pp. 155-173.
11. Choi, JS, MacKay, JA and Szoka Jr, FC (2003) Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: Preparation and characterization. Bioconjug Chem, 14, pp. 420-429.
12. Daemen, T., Veninga, A., Roerdink, FH and Scherphof, GL (1986) In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res, 46, pp. 4330-4335.
13. Derksen, JTP and Scherphof, GL (1985) An improved method for the covalent coupling of proteins to liposomes. Biochim Biophys Acta, 814, p. 151.
14. Yazidi-Belkoura, I El, Legrand, D., Nuijens, J., Slomianny, MC, van Berkel, P. and Spik, G. (2001) The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus. Biochim Biophys Acta, 1568, pp. 197-204.
15. George St, JA (2003) Gene therapy progress and prospects: Adenoviral vectors. Gene Ther, 10, pp. 1135-1141.
16. Furmanski, P. (1995) Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature, 373, pp. 721-724.
17. Hofland, HE, Shephard, L. and Sullivan, SM (1996) Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA, 93, pp. 7305-7309.
18. Hofland, HE, Masson, C., Iginla, S., Osetinsky, I., Reddy, JA, Leamon, CP, Scherman, D., Bessodes, M. and Wils, P. (2002) Folate-targeted gene transfer in vivo. Mol Ther, 5, pp. 739-744.
19. Imber, MJ, Pizzo, SV, Johnson, WJ and Adams, DO (1982) Selective diminution of the binding of mannose by murine macrophages in the late stages of activation. J Biol Chem, 257, pp. 5129-5135.
20. Ishida, E., Managit, C., Kawakami, S., Nishikawa, M., Yamashita, F. and Hashida, M. (2004) Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. Pharm Res, 21, pp. 932-939.
21. Ismail, M. and Brock, JH (1993) Binding of lactoferrin and transferrin to the human promonocytic cell line U937. Effect on iron uptake and release. J Biol Chem, 268, pp. 21618-21625.
22. Kamps, JAAM, Swart, PJ, Morselt, HW, Pauwels, R., De Bethune, MP, De Clercq, E., Meijer, DKF and Scherphof, GL (1996) Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: Drug carriers with an intrinsic anti-HIV activity. Biochim Biophys Acta, 1278, pp. 183-190.
23. Keidar, S., Kaplan, M. and Aviram, M. (1996) Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arterioscler Thromb Vasc Biol, 16, pp. 97-105.
24. Lee, RJ and Huang, L. (1996) Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem, 271, pp. 8481-8487.
25. Mazurier, J., Legrand, D., Hu, WL, Montreuil, J. and Spik, G. (1989) Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur J Biochem, 179, pp. 481-487.
26. Monck, MA, Mori, A., Lee, D., Tam, P., Wheeler, JJ, Cullis, PR and Scherrer, P. (2000) Stabilized plasmid-lipid particles: Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J Drug Target, 7, pp. 439-452.
27. Muller, K., Nahde, T., Fahr, A., Muller, R. and Brusselbach, S. (2001) Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther, 8, pp. 107-117.
28. Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K. and Kato, N. (2003) Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J Biol Chem, 278, pp. 10162-10173.
29. Nuijens, JH, van Berkel, PH and Schanbacher, FL (1996) Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia, 1, pp. 285-295.
30. Palmer, LR, Chen, T., Lam, AMI, Fenske, DB, Wong, KF, MacLachlan, I. and Cullis, PR (2003) Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. Biochim Biophys Acta, 1611, pp. 204-216.
31. Peen, E., Johansson, A., Engquist, M. and Skogh, T. (1998) Hepatic and extrahepatic clearance of circulating human lactoferrin: An experimental study in rat. Eur J Haematol, 61, pp. 151-159.
32. Penco, S., Scarfi, S., Giovine, M., Damonte, G., Millo, E., Villaggio, B., Passalacqua, M., Pozzolini, M., Garre, C. and Benatti, U. (2001) Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem, 34, pp. 151-159.
33. Peterson, GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem, 83, pp. 346-356.
34. Reddy, JA, Abburi, C., Hofland, H., Howard, SJ, Vlahov, I., Wils, P. and Leamon, CP (2002) Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther, 9, pp. 1542-1550.
35. Rigotti, A., Acton, SL and Krieger, M. (1995) The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem, 270, pp. 16221-16224.
36. Rudolph, C., Plank, C., Lausier, J., Schillinger, U., Muller, RH and Rosenecker, J. (2003) Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem, 278, pp. 11411-11418.
37. Sandhu, AP, Lam, AMI, Fenske, DB, Palmer, LR, Johnston, M. and Cullis, PR (2005) Calcium enhances the transfection potency of stabilized plasmid-lipid particles. Anal Biochem, 341, pp. 156-164.
38. Saravolac, EG, Ludkovski, O., Skirrow, R., Ossanlou, M., Zhang, YP, Giesbrecht, C., Thompson, J., Thomas, S., Stark, H., Cullis, PR and Scherrer, P. (2000) Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J Drug Target, 7, pp. 423-437.
39. Schmidt, AM, Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W. and Clauss, M. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem, 267, pp. 14987-14997.
40. Shi, N. and Pardridge, WM (2000) Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA, 97, pp. 7567-7572.
41. Shi, N., Zhang, Y., Zhu, C., Boado, RJ and Pardridge, WM (2001) Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA, 98, pp. 12754-12759.
42. Ulvatne, H., Haukland, HH, Olsvik, O. and Vorland, LH (2001) Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett, 492, pp. 62-65.
43. Van Berkel, PH, Geerts, ME, van Veen, HA, Mericskay, M., de Boer, HA and Nuijens, JH (1997) N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J, 328, pp. 145-151.
44. Van Dijk, MCM, Ziere, GJ and van Berkel, TJC (1992) Characterization of the chylomicron (remnant) recognition sites on parenchymal and Kupffer cells of rat liver: Selective inhibition of parenchymal cell recognition by lactoferrin. Eur J Biochem, 205, pp. 775-784.
45. Wheeler, JJ, Palmer, L., Ossanlou, M., MacLachlan, I., Graham, RW, Zhang, YP, Hope, MJ, Scherrer, P. and Cullis, PR (1999) Stabilized plasmid-lipid particles: Construction and characterization. Gene Ther, 6, pp. 271-281.
46. Wisse, E. (1970) An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res, 31, pp. 125-150.
47. Liu, P., Zhu, L., Maddukuri, S. and Zern, MA (1998) Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology, 27, pp. 772-778.
48. Pirollo, KF, Tang, WH, Rait, A. and Chang, EH (1999) Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther, 10, pp. 2941-2952.
49. Huang, CC, Huang, W., Tang, WH, Rait, A., Yin, YZ, Cruz, I., Xiang, LM, Pirollo, KF and Chang, EH (2002) Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther, 1, pp. 337-346.
50. Ziere, GJ, van Dijk, MC, Bijsterbosch, MK and Van Berkel, TJ (1992) Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem, 267, pp. 11229-11235.
51. Ziere, GJ, Kruijt, JK, Bijsterbosch, MK and Van Berkel, TJ (1996) Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: Involvement of proteoglycans and the remnant receptor. Biochem J, 313, pp. 289-295.